News & Perspective

Oct 08, 2008

Oct 08, 2008

Two firms win NIAID support for Ebola-Marburg vaccines

(CIDRAP News) – Two biotechnology companies—Crucell, based in the Netherlands, and Integrated BioTherapeutics, based in Germantown, Md.—recently announced that they have received $30 million and $22 million contracts, respectively, from the National Institutes of Allergy and Infectious Diseases (NIAID) to develop single vaccines that would protect against both Ebola and Marburg viruses.

Oct 10, 2008

Oct 10, 2008

WHO: Mystery fever killed three in South Africa

(CIDRAP News) – The World Health Organization (WHO) today said a mysterious febrile disease that bears some resemblance to a viral hemorrhagic fever (VHF) has killed three people in Johannesburg, South Africa.

The WHO said the victims so far have tested negative for several VHFs and other infectious diseases, and no new cases have emerged since the latest death on Oct 5.